-
Business News | Boehringer Ingelheim Introduces NexGard SPECTRA for Dogs in India
18 Apr 2024 10:47 GMT
… its approval by the Central Drugs Standard Control Organisation (CDSCO). … a broad-spectrum anti-parasitic drug targeting both endo and … dogs 2014-2026. Statista.
About Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies …
-
United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com
17 Apr 2024 11:24 GMT
… diverse products. Currently, Ceva, Zoetis, Boehringer Ingelheim, Merck, Elanco, Bayer AG, … including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), laser devices, and …
VENDOR LANDSCAPE
Key Vendors
Boehringer Ingelheim
Ceva
Elanco Animal Health
…
-
Boehringer Ingelheim leans on late-stage pipeline, plots 25 new launches over the next decade
16 Apr 2024 15:19 GMT
Boehringer Ingelheim’s 2023 was largely marked … -1 receptor dual agonist, a drug class that has more than … studies.
As for its commercialized drugs, the star of the company … disease nod in hand, the drug reached new heights with 31% …
-
Boehringer Ingelheim touts 10-year plan as it eyes overtaking Bayer as Germany’s largest pharma
16 Apr 2024 13:14 GMT
Boehringer Ingelheim put the spotlight on a … of its diabetes and heart drug Jardiance, Boehringer may have surpassed …
-
Tracking Price Adjustments for the Ten Drugs negotiating with Medicare through Q1 2024
17 Apr 2024 16:00 GMT
… lowering the cost of prescription drugs. One such policy allows … & Dohme
Jardiance by Boehringer-Ingelheim
Fiasp/Novolog by Novo … top 50 Medicare Part D drugs.
We examined these products … the manufacturers of the drugs CMS will be negotiating …
-
MASH Innovator Drug Partnerships Surge Over $2.5 Billion In 2024YTD, Reveals GlobalData
17 Apr 2024 11:39 GMT
… steatohepatitis (MASH) innovator drug development. MASH innovator drugs witnessed over $2.5 … deal value.
In January 2024, Boehringer Ingelheim signed a partnership deal worth … partnership deals involving innovative MASH drugs in 2024YTD involved large …
-
HIV Drugs Market To Surpass USD 43.06 Billion By 2031, Fueled With Expanding Treatment Programs
16 Apr 2024 17:07 GMT
… ,
→Boehringer Ingelheim International,
→Abbvie, Genentech,
→Mylan,
→Others.
Download Free Sample Copy HIV Drugs … authorities.
Segmenting the HIV Drugs Market
By Drug Class
→Integrase Inhibitors
→Non …
-
Inside the booming weight loss drug market
16 Apr 2024 06:32 GMT
… drugs like Novo’s Wegovy and Lilly’s Zepbound. Amgen’s drug … has indicated GLP-1 drugs can reduce heart and … into obesity drug research, including Pfizer, Roche, AstraZeneca and Boehringer Ingelheim. With … potential for its obesity drugs to compete with Wegovy …
-
Prescription Drugs Market Size to Reach $1.4 Billion Globally by 2030: Latest Report by Vantage Market Research
15 Apr 2024 13:13 GMT
… (U.S.)
• Bayer AG (Germany)
• Boehringer Ingelheim International GmbH (Germany)
• Dr. Reddy … , rising concerns regarding counterfeit drugs and drug pricing pressures pose significant hurdles …
-
Peptic Ulcer Drugs Market Expected to Surge, Projected to Reach USD 5.59 Billion by 2031
15 Apr 2024 09:06 GMT
…
Peptic Ulcer Drugs Market Opportunity:
The peptic ulcer drug market is …
→Abbott Laboratories,
→Novitium Pharma LLC,
→Boehringer Ingelheim International GmbH,
→PharmaKing Co. Ltd … peptic ulcer drugs market can be segmented by drug class, ulcer …